Search

Search Results

• Improving Reproductive Outcomes in PCOS: The Emerging Role of GLP-1 Receptor Agonists

  Adrianna Tabeau, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Justyna Pięta, Hanna Sitarek, Joanna Prus, Marcel Chudzikowski, Agata Prokopiuk

  53347

  2025-03-25
• Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence

  Natalia Gniaź, Aleksandra Górska, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Dominika Marciniuk, Natalia Marko

  56672

  2024-12-07
• Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review

  Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

  57712

  2025-02-06
• Adverse effects of GLP – 1 Receptor Agonists

  Anna Kasprzak, Monika Kułaga, Monika Grzybek, Diana Mazur-Lesińska, Barbara Szostak, Sylwia Wielgosz-Biała, Krzysztof Tyszkiewicz, Borys Łozowski, Małgorzata Kasprzak, Barbara Wilczyńska

  57774

  2025-02-11
• The needle percentage in the leafy shoot biomass of Scots pine in climate gradients of Eurasia

  Vladimir Usoltsev, Walery Zukow, Ivan Tsepordey

  416-428

  2022-05-31
• Morphological changes in kidney glomeruli of rats with chronic toxic hepatitis and its correction with lisinopril, L-arginine-L-glutamate and their combination

  N. A. Rykalo, Yu. M. Berehovenko, O. V. Androshchuk

  632-639

  2019-05-27
• Effect of ras-blockers and no-cycle metabolites on the renal functions of rats exposed to thyroxine injections

  S. I. Dolomatov, T. P. Sataieva

  41-55

  2014-01-12
• Clinical utility of low‑frequency piezoelectric thromboelastography for global hemostasis assessment and prediction of thrombo‑hemorrhagic complications

  O. Tarabrin, R. Sukhonos, K. Kirpichnikova, Ye. Buhayenko, I. Hladkykh, O. Suslov

  67617

  2025-09-25
• Anaplastic thyroid cancer with life-threatening symptoms in an older female - a case report

  Wojciech Pawęska, Hanna Dominik, Barbara Dominik

  117-122

  2023-08-08
• The Impact of GLP-1 Analogues and Tirzepatide on Female Fertility: Mechanisms, Clinical Evidence, and Implications

  Klaudia Elżbieta Niwińska, Michał Borowski, Julia Aleksandra Leśniak, Natalia Maria Leśniak, Klaudia Martyna Patrzykąt, Anna Maria Zakrzewska, Kinga Popielarska, Julia Agnieszka Michalak, Monika Augustyn, Aleksander Midera

  67444

  2026-01-16
• GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care

  Agnieszka Parfianowicz, Alicja Surma

  57478

  2025-02-04
• GLP-1 Receptor Agonists: A New Hope in the Global Fight Against Obesity — Benefits and Health Risks

  Oskar Pastuszek, Konrad Borowski, Maja Radziwon, Emilia Bolesta-Okuniewska, Paweł Michalak, Aleksandra Marchwińska-Pancer, Katarzyna Kopeć, Julia Ceryn, Anna Wicher

  67433

  2026-01-11
• SGLT2 inhibitors in preventing progression of chronic kidney disease in patients with type 2 diabetes: a literature review

  Michał Szczepański, Marcin Kuliga, Mateusz Bajak, Julia Słowik, Julia Inglot, Jadwiga Inglot, Dominik Maciej Feret, Daniel Zapasek, Maciej Mamczur, Damian Sowa

  56369

  2024-12-08
• Innovations in Pharmacotherapy of Diabetes: A Review of Latest Reports

  Katarzyna Czechowska, Aleksandra Świerczewska, Piotr Komasara, Julia Nowakowska, Aleksandra Sędek, Lena Merchel, Ilona Bednarek, Sylwia Lach, Karol Seweryn Błąd, Kinga Kałuża

  61795

  2025-07-08
• Stronger Together: How GLP-1 RAs and SGLT-2 Inhibitors Revolutionize Type 2 Diabetes Treatment

  Hanna Sitarek, Adrianna Tabeau, Joanna Prus, Justyna Pięta, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Marcel Chudzikowski, Agata Prokopiuk

  59642

  2025-05-06